STOCK TITAN

Millennium-linked investors disclose 5%+ Ardelyx (ARDX) passive stake on 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Ardelyx, Inc. received a Schedule 13G filing from hedge fund–related entities reporting significant passive ownership of its common stock. Integrated Core Strategies (US) LLC reports beneficial ownership of 12,855,317 shares, representing 5.3% of the common stock. Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial ownership of 13,121,781 shares, or 5.4% of the class, with shared voting and dispositive power and no sole authority. The filing states that the securities were not acquired and are not held for the purpose of changing or influencing control of Ardelyx, but instead are held on a passive basis.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:01/09/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:01/09/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:01/09/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:01/09/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of January 9, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What does the Schedule 13G filing disclose about Ardelyx (ARDX)?

The filing discloses that several Millennium-affiliated entities and Israel A. Englander have filed a Schedule 13G reporting passive beneficial ownership positions in Ardelyx, Inc. common stock, each above the 5% threshold.

How many Ardelyx (ARDX) shares does Integrated Core Strategies (US) LLC report owning?

Integrated Core Strategies (US) LLC reports beneficial ownership of 12,855,317 shares of Ardelyx common stock, representing 5.3% of the outstanding class, all with shared voting and dispositive power.

What stake in Ardelyx (ARDX) is reported by Millennium Management LLC and related entities?

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial ownership of 13,121,781 Ardelyx common shares, equal to 5.4% of the class, with zero sole voting or dispositive power and full shared authority over those shares.

Is the Millennium position in Ardelyx (ARDX) described as passive or activist?

The certification states that the securities were not acquired and are not held for the purpose or effect of changing or influencing the control of Ardelyx, indicating a passive investment intent under the Schedule 13G framework.

Who signed the Ardelyx (ARDX) Schedule 13G on behalf of the reporting entities?

Gil Raviv, Global General Counsel, signed for Integrated Core Strategies (US) LLC, Millennium Management LLC and Millennium Group Management LLC, while Israel A. Englander signed in his individual capacity.

What type of Ardelyx securities are covered by this Schedule 13G?

The Schedule 13G covers Ardelyx, Inc. common stock, par value $0.0001 per share, with CUSIP number 039697107.

What is the stated event date for the Ardelyx (ARDX) Schedule 13G filing?

The date of the event requiring the Schedule 13G filing regarding Ardelyx common stock is listed as 01/05/2026.

Ardelyx

NASDAQ:ARDX

ARDX Rankings

ARDX Latest News

ARDX Latest SEC Filings

ARDX Stock Data

1.71B
235.83M
2.45%
70.91%
8.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
FREMONT